Literature DB >> 3033320

Morphf mutants of Rous sarcoma virus: nucleotide sequencing analysis suggests that a class of morphf mutants was generated through splicing of a cryptic intron.

S K Anderson, D J Fujita.   

Abstract

The nature of the lesions involved in producing the fusiform phenotype of three mutants (WO101, WO201, and tsST529) of the Schmidt-Ruppin A strain of Rous sarcoma virus (RSV) was determined by molecular cloning and DNA sequencing. WO101 and WO201 contained an in-frame deletion of the v-src region coding for amino acids 116 to 140 of p60v-src. The deleted segment was flanked by consensus splice donor and acceptor sequences and contained an appropriately positioned branchpoint acceptor consensus sequence, suggesting that the deletion occurred through an aberrant RNA splicing event. S1 mapping experiments performed on RNA isolated from chicken cells infected with molecularly cloned wild-type RSV DNA suggested that the splice acceptor involved in the generation of this deletion was utilized at a low frequency (less than 1.0%) in wild-type RSV-infected cells. These results suggested that stable mutations may have arisen in the coding sequence of a eucaryotic viral transforming gene as a result of a probable aberrant RNA splicing event followed by reverse transcription into DNA. ST529 was found to harbor the same deletion present in WO101 and WO201 but also contained a point mutation which resulted in the substitution of lysine for glutamic acid at position 93. This change and the resulting large change in local charge were presumably required for the temperature-sensitive transformation phenotype of ST529. These results, together with other known deletions that produce fusiform mutants, suggested that a region within the amino-terminal one-third coding region of the src gene contributed to a structural domain of p60v-src that was important for controlling some morphological parameters of transformation in cells infected with RSV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033320      PMCID: PMC254195          DOI: 10.1128/JVI.61.6.1893-1900.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  A mutant of rous sarcoma virus (type O) causing fusiform cell transformation.

Authors:  S Yoshii; P K Vogt
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

2.  Physical modification of purified Rous sarcoma virus pp60v-src protein after incubation with ATP/Mg2+.

Authors:  M S Collett; S K Wells; A F Purchio
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

3.  Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation.

Authors:  D Bryant; J T Parsons
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

4.  Frameshift and intragenic suppressor mutations in a Rous sarcoma provirus suggest src encodes two proteins.

Authors:  G Mardon; H E Varmus
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

5.  Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus.

Authors:  A P Czernilofsky; A D Levinson; H E Varmus; J M Bishop; E Tischer; H Goodman
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

6.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

Authors:  T Takeya; H Hanafusa
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog.

Authors:  T Takeya; H Hanafusa
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

9.  Analysis of the sequence of amino acids surrounding sites of tyrosine phosphorylation.

Authors:  T Patschinsky; T Hunter; F S Esch; J A Cooper; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

10.  Small deletion in src of Rous sarcoma virus modifying transformation phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity.

Authors:  N Kitamura; M Yoshida
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

View more
  6 in total

1.  Deletions within the amino-terminal half of the c-src gene product that alter the functional activity of the protein.

Authors:  S P Nemeth; L G Fox; M DeMarco; J S Brugge
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

2.  Transformation of chicken embryo fibroblast cells by avian retroviruses containing the human Fyn gene and its mutated genes.

Authors:  K Semba; S Kawai; Y Matsuzawa; Y Yamanashi; M Nishizawa; K Toyoshima
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

3.  Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; H Hanafusa
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

4.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.

Authors:  S Tanaka; S Hattori; T Kurata; K Nagashima; Y Fukui; S Nakamura; M Matsuda
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3'-kinase activity with pp60v-src and alter cellular morphology.

Authors:  D S Wages; J Keefer; T B Rall; M J Weber
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.